Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients

Author： Sharma Amit   Ketteler Markus   Marshall Thomas S.   Khan Samina S.   Schumock Glen T.  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.9, 2013-09, pp. : 1129-1136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite

Impact of Vitamin D Dose on Biochemical Parameters in Patients with Secondary Hyperparathyroidism Receiving Cinacalcet

By  

Nephron Clin Pract, Vol. 112, Iss. 1, 2009-04 ,pp. : c41-c50

Karger

Access to resources Recommend Favorite

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet

By Belozeroff Vasily   Lee Andrew   Tseng Spring   Chiroli Silvia   Campbell Jonathan D.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1154-1162

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 3, 2015-06 ,pp. : 225-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 122, Iss. 1-2, 2013-03 ,pp. : 1-8

Karger

Access to resources Recommend Favorite